Internal Medicine, Endocrinology, Diabetes, & Metabolism · Fresno, CA
NPI
1871503649
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
550 E Herndon Ave, Ste 101
Fresno, CA, 93720
Phone (559) 261-0990
Medicare paid, 2024
$291K
39,109 services
Medicare patients, 2024
431
Average age 73
Drug cost, 2024
$3.2M
11,238 prescriptions
Company payments, 2025
$1,537
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul C Norwood was code J1071 (injection, testosterone cypionate, 1 mg), 32,600 times for 21 patients. In total Paul C Norwood billed 39,109 services in 46 codes, and Medicare paid $291K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 32,600 | 21 | $0.02 | $522 |
| 99214 Office E&M - Established | Office | 1,829 | 416 | $85.84 | $157K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,580 | 415 | $50.65 | $80K |
| 83036 Blood Count | Office | 726 | 272 | $9.52 | $6,912 |
| 82947 Clinical Chemistry | Office | 639 | 218 | $3.85 | $2,460 |
| 95251 Test - Miscellaneous | Office | 317 | 122 | $26.48 | $8,393 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 247 | 121 | $13.27 | $3,278 |
| 96372 Injection Administration | Office | 171 | 35 | $11.08 | $1,894 |
| G0008 Administration of influenza virus vaccine | Office | 96 | 92 | $32.73 | $3,142 |
| 90662 Vaccine Product | Office | 92 | 88 | $79.42 | $7,307 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 65 | 16 | $0.69 | $44.9 |
| 99213 Office E&M - Established | Office | 37 | 34 | $53.44 | $1,977 |
| 99205 Office E&M - New | Office | 37 | 37 | $161.52 | $5,976 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 20 | 17 | $26.11 | $522 |
| 95249 Test - Miscellaneous | Office | 17 | 17 | $53.33 | $907 |
By year: 2022 $232K for 59,052 services; 2023 $218K for 44,785 services; 2024 $291K for 39,109 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 726 | 272 | $9.52 | $6,912 |
| 82947 Clinical Chemistry | 639 | 218 | $3.85 | $2,460 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul C Norwood prescribed most often to Medicare patients was Metformin Hcl, with 551 prescriptions and refills. In total Paul C Norwood wrote 11,238 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 551 | 1,575 | 183 | $5,579 |
| Levothyroxine Sodium Generic | 513 | 1,426 | 143 | $6,894 |
| Ozempic Semaglutide | 413 | 777 | 114 | $709K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 323 | 331 | 57 | $6,455 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 289 | 813 | 92 | $4,777 |
| Omeprazole Generic | 279 | 762 | 93 | $5,790 |
| Jardiance Empagliflozin | 256 | 605 | 82 | $333K |
| Atorvastatin Calcium Generic | 237 | 684 | 77 | $2,527 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 233 | 506 | 77 | $44K |
| Amlodipine Besylate Generic | 228 | 650 | 73 | $1,638 |
| Testosterone Cypionate Generic | 220 | 439 | 58 | $9,593 |
| Alprazolam Generic | 210 | 224 | 35 | $586 |
| Methylphenidate Hcl Generic | 206 | 221 | 37 | $7,578 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 198 | 502 | 105 | $17K |
| Losartan Potassium Generic | 191 | 569 | 77 | $2,125 |
Brand drugs: 3,136 claims; generic drugs: 7,750 claims; opioid claims: 584.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul C Norwood $1,537 ($1,537 in general payments such as food, travel and fees) from 23 companies. The largest payer was Abbott Laboratories with $208.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 6 | $208 |
| Novo Nordisk Inc NVO | 10 | $203 |
| Lilly USA, LLC LLY | 13 | $193 |
| Medtronic, Inc. MDT | 8 | $185 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $121 |
| Globus Medical, Inc. GMED | 1 | $114 |
| Kyowa Kirin, Inc. 4151.T | 3 | $78.61 |
| Averitas Pharma Inc. | 2 | $59.12 |
| Xeris Pharmaceuticals, Inc. | 3 | $58.59 |
| Lexicon Pharmaceuticals, Inc. LXRX | 1 | $40 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.